These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12064632)

  • 1. Determination of a potential role of the CCN family of growth regulators in connexin43 transfected C6 glioma cells.
    McLeod TL; Bechberger JF; Naus CC
    Cell Commun Adhes; 2001; 8(4-6):441-5. PubMed ID: 12064632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression.
    Fu CT; Bechberger JF; Ozog MA; Perbal B; Naus CC
    J Biol Chem; 2004 Aug; 279(35):36943-50. PubMed ID: 15213231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent differential upregulation of CCN1/Cyr61 and CCN3/NOV by the gap junction protein Connexin43 in glioma cells.
    Sin WC; Bechberger JF; Rushlow WJ; Naus CC
    J Cell Biochem; 2008 Apr; 103(6):1772-82. PubMed ID: 18004727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells.
    Gellhaus A; Dong X; Propson S; Maass K; Klein-Hitpass L; Kibschull M; Traub O; Willecke K; Perbal B; Lye SJ; Winterhager E
    J Biol Chem; 2004 Aug; 279(35):36931-42. PubMed ID: 15181016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in the synthesis of insulin-like growth factor binding proteins and insulin-like growth factors in rat C6 glioma cells transfected with a gap junction connexin43 cDNA.
    Bradshaw SL; Naus CC; Zhu D; Kidder GM; D'Ercole AJ; Han VK
    Regul Pept; 1993 Oct; 48(1-2):99-112. PubMed ID: 7505471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of the CCN family members Cyr61, CTGF and Nov in human breast cancer.
    Jiang WG; Watkins G; Fodstad O; Douglas-Jones A; Mokbel K; Mansel RE
    Endocr Relat Cancer; 2004 Dec; 11(4):781-91. PubMed ID: 15613452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three members of the connective tissue growth factor family CCN are differentially regulated by mechanical stress.
    Schild C; Trueb B
    Biochim Biophys Acta; 2004 Apr; 1691(1):33-40. PubMed ID: 15053922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated connexin43 proteins inhibit rat glioma cell growth suppression mediated by wild-type connexin43 in a dominant-negative manner.
    Omori Y; Yamasaki H
    Int J Cancer; 1998 Nov; 78(4):446-53. PubMed ID: 9797133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression of the angiogenic regulators CYR61 (CCN1) and NOV (CCN3) in human placenta is associated with pre-eclampsia.
    Gellhaus A; Schmidt M; Dunk C; Lye SJ; Kimmig R; Winterhager E
    Mol Hum Reprod; 2006 Jun; 12(6):389-99. PubMed ID: 16675545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61).
    Brigstock DR
    Angiogenesis; 2002; 5(3):153-65. PubMed ID: 12831056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of genes differentially expressed in C6 glioma cells transfected with connexin43.
    Naus CC; Bond SL; Bechberger JF; Rushlow W
    Brain Res Brain Res Rev; 2000 Apr; 32(1):259-66. PubMed ID: 10751676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased invasive capacity of connexin43-overexpressing malignant glioma cells.
    Zhang W; Nwagwu C; Le DM; Yong VW; Song H; Couldwell WT
    J Neurosurg; 2003 Dec; 99(6):1039-46. PubMed ID: 14705732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOV (CCN3) regulation in the growth plate and CCN family member expression in cartilage neoplasia.
    Yu C; Le AT; Yeger H; Perbal B; Alman BA
    J Pathol; 2003 Dec; 201(4):609-15. PubMed ID: 14648665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and regulation of CCN genes in murine osteoblasts.
    Parisi MS; Gazzerro E; Rydziel S; Canalis E
    Bone; 2006 May; 38(5):671-7. PubMed ID: 16311085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products cause increased CCN family and extracellular matrix gene expression in the diabetic rodent retina.
    Hughes JM; Kuiper EJ; Klaassen I; Canning P; Stitt AW; Van Bezu J; Schalkwijk CG; Van Noorden CJ; Schlingemann RO
    Diabetologia; 2007 May; 50(5):1089-98. PubMed ID: 17333105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas.
    Xie D; Yin D; Wang HJ; Liu GT; Elashoff R; Black K; Koeffler HP
    Clin Cancer Res; 2004 Mar; 10(6):2072-81. PubMed ID: 15041728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant expression of Cyr61, a member of the CCN (CTGF/Cyr61/Cef10/NOVH) family, and dysregulation by 17 beta-estradiol and basic fibroblast growth factor in human uterine leiomyomas.
    Sampath D; Zhu Y; Winneker RC; Zhang Z
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1707-15. PubMed ID: 11297607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.
    Zeng ZJ; Yang LY; Ding X; Wang W
    World J Gastroenterol; 2004 Dec; 10(23):3414-8. PubMed ID: 15526358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features.
    Xie D; Nakachi K; Wang H; Elashoff R; Koeffler HP
    Cancer Res; 2001 Dec; 61(24):8917-23. PubMed ID: 11751417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Elm1 gene, a novel gene of the CCN (connective tissue growth factor, Cyr61/Cef10, and neuroblastoma overexpressed gene) family, suppresses In vivo tumor growth and metastasis of K-1735 murine melanoma cells.
    Hashimoto Y; Shindo-Okada N; Tani M; Nagamachi Y; Takeuchi K; Shiroishi T; Toma H; Yokota J
    J Exp Med; 1998 Feb; 187(3):289-96. PubMed ID: 9449709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.